United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Bexion Pharmaceuticals advances BXQ-350 cancer drug trial with phase 1 part 3 launch Bexion Pharmaceuticals has launched part 3 of its phase 1 clinical trial for BXQ-350, an investigational cancer treatment… bypharmanewsdailyFebruary 24, 2019